Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 112,620 shares of BCDA, which is worth approximately $227,492. The most recent transaction as insider was on Apr 11, 2025, when has been sold 300 shares (Common Stock) at a price of $2.03 per share, resulting in proceeds of $608. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K

5.67% 3M change

79.74% 12M change

Total Value Held $227,492

Peter Altman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 11 2025	BUY Open market or private purchase	$608 $2.03 p/Share	300 Added 0.27%	112,620 Common Stock
Apr 10 2025	BUY Open market or private purchase	$597 $1.99 p/Share	300 Added 0.27%	112,320 Common Stock
Apr 07 2025	BUY Open market or private purchase	$980 $1.96 p/Share	500 Added 0.44%	112,020 Common Stock
Apr 04 2025	BUY Open market or private purchase	$1,632 $2.04 p/Share	800 Added 0.71%	111,520 Common Stock
Apr 03 2025	BUY Open market or private purchase	$1,320 $2.2 p/Share	600 Added 0.54%	110,720 Common Stock
Apr 03 2025	BUY Open market or private purchase	$2,688 $2.24 p/Share	1,200 Added 1.08%	109,620 Common Stock
Apr 02 2025	BUY Open market or private purchase	$1,115 $2.23 p/Share	500 Added 0.45%	110,120 Common Stock
Mar 03 2025	BUY Open market or private purchase	$1,055 $2.11 p/Share	500 Added 0.46%	108,420 Common Stock
Feb 07 2025	BUY Open market or private purchase	$1,488 $2.48 p/Share	600 Added 0.55%	107,920 Common Stock
Jan 30 2025	BUY Open market or private purchase	$568 $2.38 p/Share	239 Added 0.22%	107,320 Common Stock
Jan 29 2025	BUY Open market or private purchase	$1,200 $2.4 p/Share	500 Added 0.46%	107,081 Common Stock
Dec 23 2024	BUY Open market or private purchase	$2,060 $2.06 p/Share	1,000 Added 0.93%	106,581 Common Stock
Dec 05 2024	BUY Open market or private purchase	$555 $2.22 p/Share	250 Added 0.24%	105,581 Common Stock
Nov 15 2024	BUY Open market or private purchase	$2,524 $1.87 p/Share	1,350 Added 1.27%	105,331 Common Stock
Oct 11 2024	SELL Payment of exercise price or tax liability	$57,452 $2.65 p/Share	21,680 Reduced 17.25%	103,981 Common Stock
Oct 11 2024	BUY Grant, award, or other acquisition	$117,262 $2.65 p/Share	44,250 Added 26.04%	125,661 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$124,998 $3.0 p/Share	41,666 Added 33.85%	81,411 Common Stock
Jul 01 2024	BUY Open market or private purchase	$915 $3.05 p/Share	300 Added 0.75%	39,745 Common Stock
Jun 28 2024	BUY Open market or private purchase	$598 $2.99 p/Share	200 Added 0.5%	39,445 Common Stock
Jun 21 2024	BUY Open market or private purchase	$1,645 $3.29 p/Share	500 Added 1.26%	39,245 Common Stock
Jun 14 2024	BUY Open market or private purchase	$1,760 $3.52 p/Share	500 Added 1.27%	38,745 Common Stock
Jun 10 2024	BUY Open market or private purchase	$3,360 $3.36 p/Share	1,000 Added 2.55%	38,245 Common Stock
Apr 19 2024	BUY Open market or private purchase	$1,017 $0.37 p/Share	2,750 Added 0.49%	558,697 Common Stock
Mar 28 2024	BUY Open market or private purchase	$195 $0.39 p/Share	500 Added 0.09%	555,947 Common Stock
Feb 13 2024	BUY Open market or private purchase	$49,729 $0.46 p/Share	108,108 Added 16.29%	555,447 Common Stock

Peter Altman

President and CEO

Sunnyvale, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCardia, Inc.

Track Activities on BCDA

Account